134 related articles for article (PubMed ID: 38329911)
1. Comparison of Administration of 8-Milligram and 4-Milligram Intranasal Naloxone by Law Enforcement During Response to Suspected Opioid Overdose - New York, March 2022-August 2023.
Payne ER; Stancliff S; Rowe K; Christie JA; Dailey MW
MMWR Morb Mortal Wkly Rep; 2024 Feb; 73(5):110-113. PubMed ID: 38329911
[TBL] [Abstract][Full Text] [Related]
2. Outcomes of law enforcement officer administered naloxone.
Gooley B; Weston B; Colella MR; Farkas A
Am J Emerg Med; 2022 Dec; 62():25-29. PubMed ID: 36215781
[TBL] [Abstract][Full Text] [Related]
3. Naloxone administration by law enforcement officers in New York State (2015-2020).
Pourtaher E; Payne ER; Fera N; Rowe K; Leung SJ; Stancliff S; Hammer M; Vinehout J; Dailey MW
Harm Reduct J; 2022 Sep; 19(1):102. PubMed ID: 36123614
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic Properties and Human Use Characteristics of an FDA-Approved Intranasal Naloxone Product for the Treatment of Opioid Overdose.
Krieter P; Chiang N; Gyaw S; Skolnick P; Crystal R; Keegan F; Aker J; Beck M; Harris J
J Clin Pharmacol; 2016 Oct; 56(10):1243-53. PubMed ID: 27145977
[TBL] [Abstract][Full Text] [Related]
5. Training law enforcement to respond to opioid overdose with naloxone: Impact on knowledge, attitudes, and interactions with community members.
Wagner KD; Bovet LJ; Haynes B; Joshua A; Davidson PJ
Drug Alcohol Depend; 2016 Aug; 165():22-8. PubMed ID: 27262898
[TBL] [Abstract][Full Text] [Related]
6. Police officer attitudes towards intranasal naloxone training.
Ray B; O'Donnell D; Kahre K
Drug Alcohol Depend; 2015 Jan; 146():107-10. PubMed ID: 25468814
[TBL] [Abstract][Full Text] [Related]
7. Use of naloxone nasal spray 4 mg in the community setting: a survey of use by community organizations.
Avetian GK; Fiuty P; Mazzella S; Koppa D; Heye V; Hebbar P
Curr Med Res Opin; 2018 Apr; 34(4):573-576. PubMed ID: 28535115
[TBL] [Abstract][Full Text] [Related]
8. Safety, Efficacy, and Cost of 0.4-mg Versus 2-mg Intranasal Naloxone for Treatment of Prehospital Opioid Overdose.
Thompson J; Salter J; Bui P; Herbert L; Mills D; Wagner D; Brent C
Ann Pharmacother; 2022 Mar; 56(3):285-289. PubMed ID: 34229467
[TBL] [Abstract][Full Text] [Related]
9. Effect of Intranasal vs Intramuscular Naloxone on Opioid Overdose: A Randomized Clinical Trial.
Dietze P; Jauncey M; Salmon A; Mohebbi M; Latimer J; van Beek I; McGrath C; Kerr D
JAMA Netw Open; 2019 Nov; 2(11):e1914977. PubMed ID: 31722024
[TBL] [Abstract][Full Text] [Related]
10. Intranasal Naloxone for Opioid Overdose.
Taylor JL; Lasser KE
JAMA; 2024 Jan; 331(3):250-251. PubMed ID: 38127361
[TBL] [Abstract][Full Text] [Related]
11. Law enforcement attitudes towards naloxone following opioid overdose training.
Purviance D; Ray B; Tracy A; Southard E
Subst Abus; 2017; 38(2):177-182. PubMed ID: 27715714
[TBL] [Abstract][Full Text] [Related]
12. Police Officers Can Safely and Effectively Administer Intranasal Naloxone.
Fisher R; O'Donnell D; Ray B; Rusyniak D
Prehosp Emerg Care; 2016; 20(6):675-680. PubMed ID: 27218446
[TBL] [Abstract][Full Text] [Related]
13. Descriptive Epidemiology for Community-wide Naloxone Administration by Police Officers and Firefighters Responding to Opioid Overdose.
Heavey SC; Delmerico AM; Burstein G; Moore C; Wieczorek WF; Collins RL; Chang YP; Homish GG
J Community Health; 2018 Apr; 43(2):304-311. PubMed ID: 28852906
[TBL] [Abstract][Full Text] [Related]
14. American College of Medical Toxicology and the American Academy of Clinical Toxicology position statement: nalmefene should not replace naloxone as the primary opioid antidote at this time.
Stolbach AI; Mazer-Amirshahi ME; Nelson LS; Cole JB
Clin Toxicol (Phila); 2023 Nov; 61(11):952-955. PubMed ID: 38039052
[TBL] [Abstract][Full Text] [Related]
15. Management of Suspected Opioid Overdose With Naloxone in Out-of-Hospital Settings: A Systematic Review.
Chou R; Korthuis PT; McCarty D; Coffin PO; Griffin JC; Davis-O'Reilly C; Grusing S; Daya M
Ann Intern Med; 2017 Dec; 167(12):867-875. PubMed ID: 29181532
[TBL] [Abstract][Full Text] [Related]
16. Real-world study of multiple naloxone administration for opioid overdose reversal among bystanders.
Abdelal R; Raja Banerjee A; Carlberg-Racich S; Darwaza N; Ito D; Shoaff J; Epstein J
Harm Reduct J; 2022 May; 19(1):49. PubMed ID: 35596213
[TBL] [Abstract][Full Text] [Related]
17. A national survey of law enforcement post-overdose response efforts.
Ray B; Richardson NJ; Attaway PR; Smiley-McDonald HM; Davidson P; Kral AH
Am J Drug Alcohol Abuse; 2023 Mar; 49(2):199-205. PubMed ID: 36820614
[No Abstract] [Full Text] [Related]
18. Controversies and carfentanil: We have much to learn about the present state of opioid poisoning.
Cole JB; Nelson LS
Am J Emerg Med; 2017 Nov; 35(11):1743-1745. PubMed ID: 28851500
[No Abstract] [Full Text] [Related]
19. An exploratory study of a hands-on naloxone training for rural clinicians and staff.
Cody SL; Hines CB; Glenn CJ; Sharp-Marbury R; Newman S
J Nurs Scholarsh; 2023 May; 55(3):599-604. PubMed ID: 36411494
[TBL] [Abstract][Full Text] [Related]
20. Beyond rescue: Implementation and evaluation of revised naloxone training for law enforcement officers.
Dahlem CHG; King L; Anderson G; Marr A; Waddell JE; Scalera M
Public Health Nurs; 2017 Nov; 34(6):516-521. PubMed ID: 28983963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
